Senetek PLC
HILTON HEAD, South Carolina, March 18, 2011 - Senetek Plc (OTC Bulletin Board: SNKTY) is pleased to announce it has
closed the acquisition of all of the issued and outstanding shares of Iron
Eagle Acquisitions, Inc., a Nevada corporation.
NAPA, California - Additional Group of Compounds and Enhanced Research Activities Added to Agreement
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced a six year extension of existing rights under its agreement with the Czech Republic Institute of Experimental Botany to receive exclusive global licenses, for all applications, to any cytokinin developed, in-licensed or otherwise acquired by the Institute and the right to co-exploit with the Institute any cytokinins that Senetek does not elect to in-license.
NAPA, California - Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced results for the quarter ended March 31, 2009.
NAPA, California - Call +1-877-SENETEK or +1-707-259-6278
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced that an up-to-date audio recording of Company news and developments is now available by calling +1-877-SENETEK in the United States and Canada and +1-707-259-6278 from international locations.
NAPA, California - 12-week study concludes that new cosmeceutical improves skin barrier function, erythema and lesions associated with rosacea -
Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, today announced that the clinical study entitled "Topical PRK-124 (0.125%) Lotion for Improving the Signs and Symptoms of Rosacea," has been published in the May issue of Journal of Drugs in Dermatology, a peer-reviewed dermatologic publication.
